Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Amethyst Innovations is a healthcare technology company specializing in artificial intelligence and machine learning solutions to improve clinical outcomes, particularly in the field of organ transplantation. Founded by Dr. Kim Gandy, the company develops predictive analytics and clinical decision support tools that help clinicians manage complex patient populations and optimize treatment protocols. Their platform integrates diverse data sets to provide actionable insights for chronic disease management and post-transplant care. The company's mission is to bridge the gap between complex medical data and practical clinical application to enhance patient longevity and quality of life. By utilizing advanced algorithms, Amethyst Innovations aims to reduce the incidence of organ rejection and improve long-term graft survival.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Amethyst Innovations.